George Demos admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

A former pharmaceutical executive traded on nonpublic information about an antipsychotic drug’s development, avoiding $1.3 ...

VP at Acadia Pharmaceuticals, pled guilty to insider trading, avoiding a $1.3M loss by illicitly selling shares ahead of a ...

George Demos, 64, of San Diego, knew about negative news that involved the labeling process for a prescription drug with the Food and Drug Administration, Kelly Thornton with the United States ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted to insider trading for selling more than 60,000 Acadia shares just before news broke regarding an issue with one of the company ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.